Amolyt Pharma
HealthcareBiotech & Pharma
HQ: Écully, France
Investors: 2 (1 current, 1 exited)
A biotechnology company focused on developing therapeutic peptides for rare endocrine and related diseases.
Investors (2)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |
| Eurazeo | Exited | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals